Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia

Hematol Rep. 2017 Sep 26;9(3):7029. doi: 10.4081/hr.2017.7028.
No abstract available

Keywords: Core binding factor; acute myeloid leukemia; autologous stem cell transplantation; gemtuzumab ozogamicin; immunotherapy.